A new combination of phyto-cannabinoids with no psychoactive effects is starting to interest research, it is the combination of CBD and CBG. Phyto-cannabinoids (molecules found mainly in the Cannabis sativa L. plant) act on our endocannabinoid system in their own way.

  CBD (cannabinol), for example, stimulates an enzyme called FAAH which is responsible for the production of endocannabinoids in the body. In case of shortage or overproduction it acts as a regulator. On the contrary, CBG (cannabigerol) will act directly on our receptors, the best known are CB1, CB2 and 5-HT1A. One will focus on the key, the other on the lock and the combination of both will open up the field of possibilities and optimize their assimilation by the body.

Those who praise the combination of THC and CBD do so for the same reasons, because each of these two molecules has a distinct field of action and when combined they allow for a more global action. That's why this new "pair" of non-psychoactive phytocannabinoids, CBD and CBG, is starting to interest scientists. New products, new formulas! Laboratories such as Alpha-Cat are constantly evolving, always looking for innovation in full respect of all the players around them. Source: www.alpha-cat.org